Literature DB >> 16783404

Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2).

Ingrid Langer1, Nathalie Gaspard, Patrick Robberecht.   

Abstract

1. In the light of recent findings that VPAC1 and VPAC2 receptors form homodimers and heterodimers, we have evaluated the function of these receptors coexpressed in the same cells, using whole-cell and membrane preparations. Cells expressing each receptor alone were used for comparison. 2. The study was performed on Chinese hamster ovary cells stably transfected with both human recombinant receptors and we compared receptor occupancy and adenylate cyclase activation by VIP, Ro 25-1553 - a VPAC2 selective agonist - and [K(15),R(16),L(27)]VIP(1-7)/GRF(8-27) - a VPAC1 selective agonist - on membranes prepared from each cell line and on a mixture of membranes from cells expressing each receptor individually. We also studied receptor internalization induced by the three agonists on intact cells expressing both receptors alone or together by fluorescence-activated cell sorting using monoclonal antibodies and demonstrated by using co-immunoprecipitation that the two receptors did interact.3. The results indicated that coexpression of the receptors did not modify the recognition of ligands, nor the capacity of the agonists to stimulate adenylate cyclase activity and, in intact cells, to induce internalization of the receptors.4. As a consequence, the properties of the selective ligands that were established on cell lines expressing a single population of VIP receptors were valid on cells expressing both receptors. Furthermore, the recently demonstrated VPAC1/VPAC2 receptor heterodimerization did not affect the function of either receptor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783404      PMCID: PMC1752023          DOI: 10.1038/sj.bjp.0706816

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  The angiotensin II AT2 receptor is an AT1 receptor antagonist.

Authors:  S AbdAlla; H Lother; A M Abdel-tawab; U Quitterer
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

2.  The alternatively spliced deltae13 transcript of the rabbit calcitonin receptor dimerizes with the C1a isoform and inhibits its surface expression.

Authors:  Thomas Seck; Roland Baron; William C Horne
Journal:  J Biol Chem       Date:  2003-04-09       Impact factor: 5.157

Review 3.  Seven-transmembrane receptors.

Authors:  Kristen L Pierce; Richard T Premont; Robert J Lefkowitz
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

4.  Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors.

Authors:  M G Juarranz; O Bolaños; I Gutiérrez-Cañas; E A Lerner; P Robberecht; M J Carmena; J C Prieto; N Rodríguez-Henche
Journal:  Cell Signal       Date:  2001-12       Impact factor: 4.315

5.  Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A).

Authors:  M Pfeiffer; T Koch; H Schröder; M Klutzny; S Kirscht; H J Kreienkamp; V Höllt; S Schulz
Journal:  J Biol Chem       Date:  2000-12-27       Impact factor: 5.157

6.  Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.

Authors:  M Delgado; D Ganea
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

7.  Vasoactive intestinal peptide (VIP) stimulates [Ca2+]i and cyclic AMPin CHO cells expressing Galpha16.

Authors:  I Langer; J Perret; P Vertongen; M Waelbroeck; P Robberecht
Journal:  Cell Calcium       Date:  2001-10       Impact factor: 6.817

8.  Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma.

Authors:  Wei-Qun Ding; Zhi-Jie Cheng; Judy McElhiney; Susan M Kuntz; Laurence J Miller
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

9.  Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy.

Authors:  Catherine Lavoie; Jean-Francois Mercier; Ali Salahpour; Dhiviya Umapathy; Andreas Breit; Louis-Robert Villeneuve; Wei-Zhong Zhu; Rui-Ping Xiao; Edward G Lakatta; Michel Bouvier; Terence E Hébert
Journal:  J Biol Chem       Date:  2002-07-24       Impact factor: 5.157

10.  Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis.

Authors:  Sonia Terrillon; Thierry Durroux; Bernard Mouillac; Andreas Breit; Mohammed A Ayoub; Magali Taulan; Ralf Jockers; Claude Barberis; Michel Bouvier
Journal:  Mol Endocrinol       Date:  2002-12-23
View more
  9 in total

1.  Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization.

Authors:  Kaleeckal G Harikumar; Alicja M Ball; Patrick M Sexton; Laurence J Miller
Journal:  Regul Pept       Date:  2010-06-10

2.  Immune evasion by Salmonella: exploiting the VPAC1/VIP axis in human monocytes.

Authors:  Basim Askar; John Higgins; Paul Barrow; Neil Foster
Journal:  Immunology       Date:  2019-09-11       Impact factor: 7.397

Review 3.  Conformational switches in the VPAC(1) receptor.

Authors:  Ingrid Langer
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

4.  Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery.

Authors:  Kaleeckal G Harikumar; Denise Wootten; Delia I Pinon; Cassandra Koole; Alicja M Ball; Sebastian G B Furness; Bim Graham; Maoqing Dong; Arthur Christopoulos; Laurence J Miller; Patrick M Sexton
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

5.  Dimerization in the absence of higher-order oligomerization of the G protein-coupled secretin receptor.

Authors:  Kaleeckal G Harikumar; Renee M Happs; Laurence J Miller
Journal:  Biochim Biophys Acta       Date:  2008-07-17

6.  Receptor oligomerization in family B1 of G-protein-coupled receptors: focus on BRET investigations and the link between GPCR oligomerization and binding cooperativity.

Authors:  Sarah Norklit Roed; Anne Orgaard; Rasmus Jorgensen; Pierre De Meyts
Journal:  Front Endocrinol (Lausanne)       Date:  2012-05-07       Impact factor: 5.555

7.  Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies.

Authors:  Ingrid Langer
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-30       Impact factor: 5.555

8.  The N-terminal HSDCIF motif is required for cell surface trafficking and dimerization of family B G protein coupled receptor PAC1.

Authors:  Rongjie Yu; Xiaoling Guo; Jiaping Zhong; Mei Li; Zhixing Zeng; Huahua Zhang
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

9.  Receptor oligomerization: from early evidence to current understanding in class B GPCRs.

Authors:  Stephanie Y L Ng; Leo T O Lee; Billy K C Chow
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-04       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.